Loading organizations...
§ Venture Capital · Stuttgart, Baden-Wurttemberg, Germany
Nanz Venture operates as a venture capital firm, functioning as the investment vehicle for its founder, Helmut Nanz. The firm primarily deploys capital into early-stage companies specializing in healthtech, artificial intelligence, and insurtech. It identifies and supports enterprises poised to deliver technological advancements and efficiencies within their target markets.
Helmut C. Nanz established the firm, formalizing operations with the incorporation of Helmut C. Nanz Invest GmbH on July 7, 2017. Nanz leveraged his extensive investment background and market insight, aiming to create a platform for backing promising technology companies and contributing to their growth.
Nanz Venture partners with developing companies across high-impact technological sectors, providing financial and strategic support. The firm’s vision is to foster innovation within its portfolio, advancing and transforming critical industries. Through targeted investments, Nanz Venture seeks to empower leading-edge companies, helping shape the future of technology.
Nanz Venture has 1 tracked investment across 1 company. The latest tracked deal is $11.0M Series B in Caspar Health in July 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2021 | Caspar Health | $11.0M Series B | Jens Düing | Ananda Impact Ventures, Atlantic Labs, Porterhouse Group |